Journal of Medicinal Chemistry p. 18 - 24 (1982)
Update date:2022-08-04
Topics:
Mosher, Carol W.
Wu, Helen Y.
Fujiwara, Allan N.
Acton, Edward M.
Reductive N,N-dialkylation of daunorubicin with 2,2'-oxydiacetaldehyde and NaBH3CN occurred in two steps without interruption and with cyclization to form 3'-(4-morpholinyl)-3'-deaminodaunorubicin.This derivative retained the antitumor efficacy of doxorubicin against mouse leukemia P388 but at one-fortieth the dose; hence, it is the most potent anthracycline analogue synthesized so far.The 4-methoxy-1-piperidinyl derivative, similarly prepared with 3-methoxyglutaraldehyde, showed improved efficacy against P388, though at normal doses.Results with a series of analogues indicate that incorporation of the N in the new ring and the presence of an ether O at the 4-position are critical for enhanced activity.
View Morewebsite:http://www.tbbmed.com
Contact:86--21-50498136
Address:Room 6002, Building 7-1, No.160 Basheng Road,Pudong Area,Shanghai China
Contact:+86-15995924277
Address:WuZhongOu suzhou new south road 89
Contact:+86-571-28186845
Address:Room 1224,Eastcom Mansion,398 Wensan Road,Hangzhou,310013 China
Shanghai Send Pharmaceutical Technology Co., Ltd.
website:http://www.shsendpharma.com
Contact:021-58088081, +8613585868794
Address::Room A601, Building 1,NO. 800 Qingdai Road Pudong District Shanghai,China
Jinzhou Jiutai Pharmaceutical Co.,Ltd
Contact:+86-0416-5179890
Address:No.41, Taianli, Taihe District, Jinzhou, Liaoning
Doi:10.1021/ic801138e
(2008)Doi:10.1002/anie.200801022
(2008)Doi:10.1016/j.bmc.2008.05.054
(2008)Doi:10.1021/ja107541w
(2010)Doi:10.1007/s00044-007-9036-5
(2008)Doi:10.1016/j.molstruc.2021.131013
(2021)